Home › Funds › Royce & Associates › ESPR
Royce & Associates position in ESPR
ESPERION THERAPEUTICS INC NE
Latest position (Q1 2026)2.63M sh
Reported value held$7.20M
Portfolio Weight0.07%
First reportedQ3 2025
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2025 | 2.29M | $6.08M | New |
| Q4 2025 | 3.60M | $13.33M | Add |
| Q1 2026 | 2.63M | $7.20M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding ESPR
- BlackRock Inc 22.13M sh · $69.92M · Q2 2026
- Vanguard Group 14.95M sh · $55.30M · Q4 2025
- Goldman Sachs Group 10.38M sh · $32.80M · Q2 2026
- Two Sigma Investments 7.13M sh · $22.52M · Q2 2026
- Geode Capital Management 6.63M sh · $20.96M · Q2 2026
- Balyasny Asset Management 4.65M sh · $14.71M · Q2 2026
- Fidelity Management & Research (FMR) 4.61M sh · $14.58M · Q2 2026
- UBS Group AG 3.84M sh · $12.12M · Q2 2026
- Northern Trust Corp 2.32M sh · $7.34M · Q2 2026
- Millennium Management 2.23M sh · $7.03M · Q2 2026
- Fidelity International (FIL) 2.11M sh · $6.66M · Q2 2026
- JPMorgan Chase & Co 1.40M sh · $4.40M · Q2 2026